Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation.

Vigneswaran, Janani; Tan, Yi-Hung Carol; Murgu, Septimiu D; Won, Brian M; Patton, Kathryn Alexa; Villaflor, Victoria M; Hoffman, Philip C; Hensing, Thomas; Hogarth, D Kyle; Malik, Renuka; MacMahon, Heber; Mueller, Jeffrey; Simon, Cassie A; Vigneswaran, Wickii T; Wigfield, Christopher H; Ferguson, Mark K; Husain, Aliya N; Vokes, Everett E; Salgia, Ravi.
Oncotarget; 7(14): 18876-86, 2016 Apr 05.
Artigo em Inglês | MEDLINE | ID: mdl-26934441